2 terminated. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 2 | Terminated 2 |
Follow Hematoma: new trials by email Literature Review of Hematoma trials Research Report on Hematoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tocilizumab (RoActemra) and Tranexamic Acid (Cyklokapron) Used as Adjuncts to Chronic Subdural Hematoma Surgery Tranexamic acid and Tocilizumab - Chronic Subdural Hematoma | Phase 2 / Phase 3 | Terminated | Oslo University Hospital | 382 | 2017-11-28 | 2021-10-13 |
| Dexamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma Dexamethasone, Burr Hole Craniostomy - Chronic Subdural Hematoma | Phase 2 / Phase 3 | Terminated | University of Virginia | 10 | 2014-03-01 | 2018-12-11 |
Hematoma, Subdural, Chronic (2)
Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Chronic Disease (2) · Craniocerebral Trauma (2) · Disease Attributes (2) · Hematoma, Subdural (2) · Hemorrhage (2) · Intracranial Hemorrhage, Traumatic (2) · Intracranial Hemorrhages (2) · Nervous System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Dexamethasone (1) · Tranexamic Acid (1) · tocilizumab (1)
Oslo University Hospital (1) · University of Virginia (1)
Norway (1) · United States (1)
Jennifer De Jong (1) · Milo Stanisic (1)
2017 (1)